These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4117427)

  • 1. Neurotoxicity of clioquinol in laboratory animals.
    Tateishi J; Kuroda S; Saito A; Otsuki S
    Lancet; 1972 Nov; 2(7786):1095. PubMed ID: 4117427
    [No Abstract]   [Full Text] [Related]  

  • 2. S.M.O.N.
    Spillane JD
    Lancet; 1972 Jan; 1(7742):154. PubMed ID: 4109013
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurotoxicity of oxyquinolines.
    Hansson O; Herxheimer A
    Lancet; 1980 Jun; 1(8180):1253-4. PubMed ID: 6104069
    [No Abstract]   [Full Text] [Related]  

  • 4. Subacute myelo-optic neuropathy in Australia.
    Selby G
    Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
    [No Abstract]   [Full Text] [Related]  

  • 5. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
    Bron HL; Korten JJ; Pinckers AJ; Majoor CL
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiosyncratic neurotoxicity: clioquinol and bismuth.
    Lancet; 1980 Apr; 1(8173):857-8. PubMed ID: 6103216
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neurotoxic symptoms following clioquinol (Enterovioform)].
    Pannekoek JH
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1611-5. PubMed ID: 4262824
    [No Abstract]   [Full Text] [Related]  

  • 8. Clioquinol: time to act.
    de Pinto O; Burley D
    Lancet; 1977 Jun; 1(8024):1256. PubMed ID: 68347
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
    Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
    Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
    [No Abstract]   [Full Text] [Related]  

  • 10. Halogenated oxyquinoline derivatives and neurological syndromes.
    Shimada Y; Tsuji T; Igata A; Steinitz H
    Lancet; 1971 Jul; 2(7714):41-3. PubMed ID: 4103679
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral neuropathy in rats fed with clioquinol.
    Jones EL; Searle CE; Smith WT
    J Pathol; 1972 Jul; 107(3):P8-9. PubMed ID: 4263803
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of neurotoxicity of clioquinol, ethambutol, isoniazid and chloramphenicol in dogs.
    Tateishi J
    Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):11-7. PubMed ID: 4275984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Polyneuropathy following long-term use of clioquinol (Enterovioform)].
    van Beeck JA; Scholten JB
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1621-2. PubMed ID: 4262827
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurotoxicity of clioquinol. 1. Oral administration of clioquinol to several species of animals.
    Tateishi J; Kuroda S; Saito A; Otsuki S
    Seishin Shinkeigaku Zasshi; 1972 Sep; 74(9):739-55. PubMed ID: 4630865
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental reproduction of SMON in animals by prolonged administration of clioquinol: clinico-pathological findings.
    Tateishi J; Otsuki S
    Jpn J Med Sci Biol; 1975; 28 Suppl():165-86. PubMed ID: 136536
    [No Abstract]   [Full Text] [Related]  

  • 16. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
    Selby G
    Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
    [No Abstract]   [Full Text] [Related]  

  • 17. Subacute myelo-optico-neuropathy (SMON).
    Nelson E
    Ann Intern Med; 1972 Sep; 77(3):468-70. PubMed ID: 4262315
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelopathy after clioquinol treatment.
    Osterman PO
    Lancet; 1971 Sep; 2(7723):544. PubMed ID: 4105685
    [No Abstract]   [Full Text] [Related]  

  • 19. Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey.
    Nakae K; Yamamoto S; Shigematsu I; Kono R
    Lancet; 1973 Jan; 1(7796):171-3. PubMed ID: 4118793
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3].
    Aoyama H; Oira M; Ota T; Yoshioka S; Yoshida T
    Nihon Eiseigaku Zasshi; 1970 Dec; 25(5):468-71. PubMed ID: 4251106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.